|RFx ID :||21504218|
|Tender Name :||Request for Proposals - Supply of a CDK4/CDK6 Inhibitor for the Treatment of HR-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer|
|Reference # :||A1300449|
|Open Date :||Sunday, 1 September 2019 1:00 PM (Pacific/Auckland UTC+12:00)|
|Close Date :||Monday, 14 October 2019 5:00 PM (Pacific/Auckland UTC+13:00)|
|Tender Type :||Request for Proposals (RFP)|
|Tender Coverage :||Sole Agency [?]|
|Exemption Reason :||None|
|Required Pre-qualifications :||None|
04 831 5016
|Alternate Physical Delivery Address :|
|Alternate Physical Fax Number :|
|Agency Address :|
REQUEST FOR PROPOSALS – SUPPLY OF A CDK4/CDK6 INHIBITOR FOR THE TREATMENT OF HR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER
PHARMAC invites proposals for the supply of a CDK4/CDK6 inhibitor for the treatment of HR-positive, HER2-negative locally advanced or metastatic breast cancer in New Zealand.
This request for proposals (RFP) letter incorporates the following schedules:
· Schedule 1 specifies the pharmaceutical for which PHARMAC is requesting proposals and sets out the background to the RFP and the types of proposals sought;
· Schedule 2 describes the process that PHARMAC expects to follow in relation to the RFP;
· Schedule 3 sets out information about the estimated size of the current subsidised market for the pharmaceutical; and
· Schedule 4 contains the RFP form in which you are to provide details of your proposal.
If you wish to submit a proposal, you must submit it to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz) no later than 5.00 p.m. on 14 October 2019.
If you have any questions about this RFP, please post these on GETS; responses to all questions will be published on GETS.
We look forward to receiving your proposal.
This tender has been awarded.